Increased p38, but not ERK1/2, phosphorylation was also detected after S100A6 overexpression in nasopharyngeal carcinoma cells, while an adverse effect was observed after S100A6 silencing [116]. The gene discussed is S100A6; the disease is nasopharyngeal carcinoma.